After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.

Analysts' ratings for Inari Medical (NASDAQ:NARI) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...